Description
| Specialty | COARAVEN | 
|---|---|
| Dosage | 25 mg, 300 mg | 
| Form | Film-coated tablet | 
| Presentation | Box of 30 | 
| Primary packaging | Blister | 
| Specification | Opaque white PVC/PVDC/Alu | 
| INN | Hydrochlorothiazide | 
| VEIC Classification | Essential | 
| Therapeutic class | Cardiovascular system | 
| Subclass | Agents acting on the renin-angiotensin system | 
| Laboratory | PHILADELPHIA PHARMA | 
| Schedule | A | 
| Shelf life | 24 months | 
| Generic/Originator | Generic | 
| Marketing Authorization (MA) | 9353044 | 
| MA date | 2014-03-14 | 
| Range | Cardio-Metabolic Range | 







Reviews
There are no reviews yet.